✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Abbott India Ltd.

ABBOTINDIA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹61,451 Cr.
P/E
40.72

Abbott India Ltd.

  • Abbott India
  • Alkem Laboratories
  • Glenmark Pharma
  • TJI Pharma

FAQs on Abbott India Ltd. Shareprice

Abbott India has given lower returns compared to its competitors.
Abbott India has grown at ~11.12% over the last 2yrs while peers have grown at a median rate of 11.8%

Abbott India is not expensive.
Latest PE of Abbott India is 40.69, while 3 year average PE is 49.73.
Also latest EV/EBITDA of Abbott India is 33.17 while 3yr average is 37.27.

View FAQ's On Business

Growth Table

  • Abbott India Ltd.
  • Alkem Laboratories
  • Glenmark Pharma

Balance Sheet

  • Abbott India Ltd.
  • Alkem Laboratories
  • Glenmark Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Abbott India Ltd.
  • Alkem Laboratories
  • Glenmark Pharma

Cash Flow

  • Abbott India Ltd.
  • Alkem Laboratories
  • Glenmark Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Abbott India Ltd.
  • Alkem Laboratories
  • Glenmark Pharma

Quarterly Results

  • Abbott India Ltd.
  • Alkem Laboratories
  • Glenmark Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Abbott India Ltd. Financials

Balance sheet of Abbott India is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Abbott India is increasing.
Latest net debt of Abbott India is -₹1,279.25 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹3,255.84 Crs.

Yes, profit is increasing.
The profit of Abbott India is ₹1,509 Crs for TTM, ₹1,414 Crs for Mar 2025 and ₹1,201 Crs for Mar 2024.

The company seems to pay a good stable dividend.
Abbott India latest dividend payout ratio is 71.36% and 3yr average dividend payout ratio is 72.21%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech